Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer
2013
The characteristics of bladder cancer after radiotherapy for prostate cancer
2012
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles
2002
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
The Gray Lecture 2001: coming technical advances in radiation oncology
2002
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Effects of motion on the total dose distribution
2004
Relative biological effectiveness (RBE) values for proton beam therapy
2002 Standout
Nasopharyngeal carcinoma
2019 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery
2003
Conformity index: A review
2006 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
2005
Nasopharyngeal carcinoma
2015 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments
2003
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Late effects from hadron therapy
2004
Feasibility and Efficacy of Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined with Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer
2009
Direct targeting of genetically modified tumour cells to FcγRI triggers potent tumour cytotoxicity
2005
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Multisegmented Tangential Breast Fields: a Rational Way to Treat Breast Cancer
2008
Head and Neck Cancer
2020 Standout
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Bladder Cancer
2020 Standout
The preparation of magnetic nanoparticles for applications in biomedicine
2003 Standout
La radiothérapie conformationnelle est-elle un progrès? Quelles en sont les difficultés et les limites?
2001
Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum
2006
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
Works of Norbert Lombriser being referenced
The Impact of Dose Escalation on Secondary Cancer Risk After Radiotherapy of Prostate Cancer
2007
The Impact of IMRT and Proton Radiotherapy on Secondary Cancer Incidence
2006
Influence of respiration‐induced organ motion on dose distributions in treatments using enhanced dynamic wedges
2001
Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy
2004
Comparative Risk Assessment of Secondary Cancer Incidence after Treatment of Hodgkin's Disease with Photon and Proton Radiation
2000